Trials / Completed
CompletedNCT04704739
Evaluation of Mass Balance and Absolute Bioavailability of GLPG1205
A Phase 1, Open-label Study to Investigate the Pharmacokinetics and Metabolism of GLPG1205 in Healthy Male Subjects Following Single Intravenous [14C]-GLPG1205 Microtracer and Single Oral [14C]-GLPG1205 Administration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Galapagos NV · Industry
- Sex
- Male
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
A study in healthy male volunteers to assess how the radiolabelled test medicine is taken up and broken down by the body when given by short infusion into a vein and when given by the mouth in the form of a capsule or tablet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GLPG1205 film-coated tablets | Single oral dose of GLPG1205 |
| DRUG | [14C]-GLPG1205 solution for infusion | A 15-minute IV infusion of \[14C\]-GLPG1205 |
| DRUG | GLPG1205 capsules | Single oral dose of GLPG1205 as solid formulation |
Timeline
- Start date
- 2021-01-13
- Primary completion
- 2021-03-02
- Completion
- 2021-03-10
- First posted
- 2021-01-12
- Last updated
- 2021-03-25
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04704739. Inclusion in this directory is not an endorsement.